Latest V. Craig Jordan Stories
HOUSTON, July 23, 2014 /PRNewswire-USNewswire/ -- V.
ASCO expert panel includes University of New England researcher Nananda Col, M.D., M.P.H. Biddeford, ME (PRWEB) July 16, 2013 The
Drinking coffee could decrease the risk of breast cancer recurring in patients taking the widely used drug Tamoxifen.
Recent research indicates medications such as Tamoxifen or Raloxifene considerably reduce the risk of developing breast cancer in post-menopausal women.
Breast cancer is the second most common cancer among women, with more than 200,000 women diagnosed each year.
A study by researchers from the Georgetown Lombardi Comprehensive Cancer Center at Georgetown University Medical Center (GUMC) identifies a potential new combination therapy to "rescue" treatment sensitivity to fulvestrant in estrogen receptor positive breast cancers.
For women with hormone receptor-positive breast cancers, treatment after initial surgery is straightforward: a daily dose of an anti-hormone drug will block the tumor from fuel needed for growth, and keep the breast cancer at bay.
SEATTLE, March 5 /PRNewswire/ -- Women who take some types of bone-building drugs used to prevent and treat osteoporosis may be at lower risk of breast cancer, according to a study by U.S.
EMERYVILLE, Calif., Oct. 20 /PRNewswire-FirstCall/ -- Bionovo Inc. (Nasdaq: BNVI) announced today the publication of results from its study on the inhibitory effect of tamoxifen on estrogen receptor beta (ERb) gene regulation.
- totally perplexed and mixed up.